These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 28881484

  • 1. Primary cells in BCR/FGFR1-positive 8p11 myeloproliferative syndrome are sensitive to dovitinib, ponatinib, and dasatinib.
    Landberg N, Dreimane A, Rissler M, Billström R, Ågerstam H.
    Eur J Haematol; 2017 Nov; 99(5):442-448. PubMed ID: 28881484
    [Abstract] [Full Text] [Related]

  • 2. Activity of TKI258 against primary cells and cell lines with FGFR1 fusion genes associated with the 8p11 myeloproliferative syndrome.
    Chase A, Grand FH, Cross NC.
    Blood; 2007 Nov 15; 110(10):3729-34. PubMed ID: 17698633
    [Abstract] [Full Text] [Related]

  • 3. Functional characterization, localization, and inhibitor sensitivity of the TPR-FGFR1 fusion in 8p11 myeloproliferative syndrome.
    Malli T, Buxhofer-Ausch V, Rammer M, Erdel M, Kranewitter W, Rumpold H, Marschon R, Deutschbauer S, Simonitsch-Klupp I, Valent P, Muellner-Ammer K, Sebesta C, Birkner T, Webersinke G.
    Genes Chromosomes Cancer; 2016 Jan 15; 55(1):60-8. PubMed ID: 26391436
    [Abstract] [Full Text] [Related]

  • 4. Activity of fibroblast growth factor receptor inhibitors TKI258, ponatinib and AZD4547 against TPR‑FGFR1 fusion.
    Qiu XH, Li F, Cao HQ, Shao JJ, Mei JG, Li HQ, Zhai YP.
    Mol Med Rep; 2017 Mar 15; 15(3):1024-1030. PubMed ID: 28138694
    [Abstract] [Full Text] [Related]

  • 5. Screening of drugs to treat 8p11 myeloproliferative syndrome using patient-derived induced pluripotent stem cells with fusion gene CEP110-FGFR1.
    Yamamoto S, Otsu M, Matsuzaka E, Konishi C, Takagi H, Hanada S, Mochizuki S, Nakauchi H, Imai K, Tsuji K, Ebihara Y.
    PLoS One; 2015 Mar 15; 10(3):e0120841. PubMed ID: 25803811
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Functional characterization of two rare BCR-FGFR1+ leukemias.
    Barnes EJ, Leonard J, Medeiros BC, Druker BJ, Tognon CE.
    Cold Spring Harb Mol Case Stud; 2020 Apr 15; 6(2):. PubMed ID: 31980503
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A case of 8p11 myeloproliferative syndrome with BCR-FGFR1 gene fusion presenting with trilineage acute leukemia/lymphoma, successfully treated by cord blood transplantation.
    Morishige S, Oku E, Takata Y, Kimura Y, Arakawa F, Seki R, Imamura R, Osaki K, Hashiguchi M, Yakushiji K, Mizuno S, Yoshimoto K, Nagafuji K, Ohshima K, Okamura T.
    Acta Haematol; 2013 Apr 15; 129(2):83-9. PubMed ID: 23171834
    [Abstract] [Full Text] [Related]

  • 10. [The 8p11 myeloproliferative syndrome: a review of recent literature].
    Kirito K.
    Rinsho Ketsueki; 2019 Apr 15; 60(9):1157-1165. PubMed ID: 31597839
    [Abstract] [Full Text] [Related]

  • 11. Favorable outcome of allogeneic hematopoietic cell transplantation for 8p11 myeloproliferative syndrome associated with BCR-FGFR1 gene fusion.
    Dolan M, Cioc A, Cross NC, Neglia JP, Tolar J.
    Pediatr Blood Cancer; 2012 Jul 15; 59(1):194-6. PubMed ID: 22106025
    [Abstract] [Full Text] [Related]

  • 12. A case of a patient characterized by t(8;22)(p11;q11) and BCR/FGFR1 fusion gene, who was successfully treated with haploidentical hematopoietic stem cell transplantation.
    Chen X, Huang L, Zheng C, Wang Z.
    Hematology; 2021 Dec 15; 26(1):691-696. PubMed ID: 34493159
    [Abstract] [Full Text] [Related]

  • 13. Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: the first fusion gene involving BCR but not ABL.
    Fioretos T, Panagopoulos I, Lassen C, Swedin A, Billström R, Isaksson M, Strömbeck B, Olofsson T, Mitelman F, Johansson B.
    Genes Chromosomes Cancer; 2001 Dec 15; 32(4):302-10. PubMed ID: 11746971
    [Abstract] [Full Text] [Related]

  • 14. Modeling the human 8p11-myeloproliferative syndrome in immunodeficient mice.
    Agerstam H, Järås M, Andersson A, Johnels P, Hansen N, Lassen C, Rissler M, Gisselsson D, Olofsson T, Richter J, Fan X, Ehinger M, Fioretos T.
    Blood; 2010 Sep 23; 116(12):2103-11. PubMed ID: 20554971
    [Abstract] [Full Text] [Related]

  • 15. B-cell acute lymphoblastic leukemia as evolution of a 8p11 myeloproliferative syndrome with t(8;22)(p11;q11) and BCR-FGFR1 fusion gene.
    Baldazzi C, Iacobucci I, Luatti S, Ottaviani E, Marzocchi G, Paolini S, Stacchini M, Papayannidis C, Gamberini C, Martinelli G, Baccarani M, Testoni N.
    Leuk Res; 2010 Oct 23; 34(10):e282-5. PubMed ID: 20594995
    [No Abstract] [Full Text] [Related]

  • 16. Allogeneic hematopoietic stem cell transplantation for 8p11 myeloproliferative syndrome with BCR-FGFR1 gene rearrangement: a case report and literature review.
    Konishi Y, Kondo T, Nakao K, Asagoe K, Otsuka Y, Nishikori M, Hishizawa M, Yamashita K, Takaori-Kondo A.
    Bone Marrow Transplant; 2019 Feb 23; 54(2):326-329. PubMed ID: 30087462
    [No Abstract] [Full Text] [Related]

  • 17. 8p11 Myeloproliferative syndrome with BCR-FGFR1 rearrangement presenting with T-lymphoblastic lymphoma and bone marrow stromal cell proliferation: a case report and review of the literature.
    Kim SY, Oh B, She CJ, Kim HK, Jeon YK, Shin MG, Yoon SS, Lee DS.
    Leuk Res; 2011 May 23; 35(5):e30-4. PubMed ID: 21239058
    [No Abstract] [Full Text] [Related]

  • 18. Distinct stem cell myeloproliferative/T lymphoma syndromes induced by ZNF198-FGFR1 and BCR-FGFR1 fusion genes from 8p11 translocations.
    Roumiantsev S, Krause DS, Neumann CA, Dimitri CA, Asiedu F, Cross NC, Van Etten RA.
    Cancer Cell; 2004 Mar 23; 5(3):287-98. PubMed ID: 15050920
    [Abstract] [Full Text] [Related]

  • 19. Response to Tyrosine Kinase Inhibitors in Myeloproliferative Neoplasia with 8p11 Translocation and CEP110-FGFR1 Rearrangement.
    Wehrli M, Oppliger Leibundgut E, Gattiker HH, Manz MG, Müller AM, Goede JS.
    Oncologist; 2017 Apr 23; 22(4):480-483. PubMed ID: 28242791
    [Abstract] [Full Text] [Related]

  • 20. The 8p11 myeloproliferative syndrome: a distinct clinical entity caused by constitutive activation of FGFR1.
    Macdonald D, Reiter A, Cross NC.
    Acta Haematol; 2002 Apr 23; 107(2):101-7. PubMed ID: 11919391
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.